These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12088158)

  • 1. Effects of antidepressant treatment on the quality of daily life: an experience sampling study.
    Barge-Schaapveld DQ; Nicolson NA
    J Clin Psychiatry; 2002 Jun; 63(6):477-85. PubMed ID: 12088158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone and imipramine for the treatment of major depression in the elderly.
    Schweizer E; Rickels K; Hassman H; Garcia-España F
    J Clin Psychiatry; 1998 Apr; 59(4):175-83. PubMed ID: 9590668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks.
    Philipp M; Kohnen R; Hiller KO
    BMJ; 1999 Dec; 319(7224):1534-8. PubMed ID: 10591711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study.
    Chemerinski E; Robinson RG; Arndt S; Kosier JT
    J Nerv Ment Dis; 2001 Jul; 189(7):421-5. PubMed ID: 11504318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition.
    Bruijn JA; Moleman P; Mulder PG; van den Broek WW
    J Clin Psychiatry; 1998 Dec; 59(12):657-63. PubMed ID: 9921699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in daily life experience associated with clinical improvement in depression.
    Barge-Schaapveld DQ; Nicolson NA; van der Hoop RG; De Vries MW
    J Affect Disord; 1995 May; 34(2):139-54. PubMed ID: 7665806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressed in-patients respond differently to imipramine and mirtazapine.
    Bruijn JA; Moleman P; Mulder PG; van den Broek WW
    Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.
    Nunes EV; Quitkin FM; Donovan SJ; Deliyannides D; Ocepek-Welikson K; Koenig T; Brady R; McGrath PJ; Woody G
    Arch Gen Psychiatry; 1998 Feb; 55(2):153-60. PubMed ID: 9477929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine as treatment for depression in addicts.
    Kleber HD; Weissman MM; Rounsaville BJ; Wilber CH; Prusoff BA; Riordan CE
    Arch Gen Psychiatry; 1983 Jun; 40(6):649-53. PubMed ID: 6342564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms.
    Cox ID; Hann CM; Kaski JC
    Eur Heart J; 1998 Feb; 19(2):250-4. PubMed ID: 9519318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
    Kocsis JH; Zisook S; Davidson J; Shelton R; Yonkers K; Hellerstein DJ; Rosenbaum J; Halbreich U
    Am J Psychiatry; 1997 Mar; 154(3):390-5. PubMed ID: 9054788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in depression: daily life determinants and variability.
    Barge-Schaapveld DQ; Nicolson NA; Berkhof J; deVries MW
    Psychiatry Res; 1999 Nov; 88(3):173-89. PubMed ID: 10622339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo-Controlled Trial.
    Limsrivilai J; Charatcharoenwitthaya P; Pausawasdi N; Leelakusolvong S
    Am J Gastroenterol; 2016 Feb; 111(2):217-24. PubMed ID: 26753892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
    Gründer G; Wetzel H; Schlösser R; Benkert O
    Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.